カテゴリ： MarketLine, アメリカ, 企業調査

Ultragenyx Pharmaceutical Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4165
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：49
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Ultragenyx Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Ultragenyx Pharmaceutical Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ultragenyx Pharmaceutical Inc. (Ultragenyx or ‘the company’) is a clinical-stage bio-pharmaceutical company. The company classifies its business in a single business: the identification, acquisition, development and commercialization of novel products for the treatment of rare and ultra-rare diseases. It develops KRN23 (UX023) for the treatment of X-linked hypophosphatemia (XLH, a rare genetic disease that impairs bone growth); and tumor-induced osteomalacia It mainly operates in the US. The company also has a partnership with Takeda Pharmaceutical Company Limited to develop and commercialize therapies to treat rare genetic diseases. Ultragenyx is headquartered in Novato, California, the US.

Scope

- Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on Ultragenyx Pharmaceutical Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ultragenyx Pharmaceutical Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Ultragenyx Pharmaceutical Inc.: Company Overview
Ultragenyx Pharmaceutical Inc.: Overview and Key Facts
Ultragenyx Pharmaceutical Inc.: Overview
Ultragenyx Pharmaceutical Inc.: Key Facts
Ultragenyx Pharmaceutical Inc.: Key Employees
Ultragenyx Pharmaceutical Inc.: Key Employee Biographies
Ultragenyx Pharmaceutical Inc.: Major Products and Services
Ultragenyx Pharmaceutical Inc.: Company History
Ultragenyx Pharmaceutical Inc.: Management Statement
Ultragenyx Pharmaceutical Inc.: Key Competitors
Ultragenyx Pharmaceutical Inc.: Company Analysis
Ultragenyx Pharmaceutical Inc.: Business Description
Ultragenyx Pharmaceutical Inc.: SWOT Analysis
Ultragenyx Pharmaceutical Inc.: SWOT Overview
Ultragenyx Pharmaceutical Inc.: Strengths
Ultragenyx Pharmaceutical Inc.: Weaknesses
Ultragenyx Pharmaceutical Inc.: Opportunities
Ultragenyx Pharmaceutical Inc.: Threats
Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity
Ultragenyx Pharmaceutical Inc.: Financial Deals Overview
Ultragenyx Pharmaceutical Inc.: Targets and Partners
Ultragenyx Pharmaceutical Inc.: Top Deals 2016 – 2020YTD*
Ultragenyx Pharmaceutical Inc.: Advisors
Ultragenyx Pharmaceutical Inc.: Top Legal Advisors
Ultragenyx Pharmaceutical Inc.: Top Financial Advisors
Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions
Ultragenyx Pharmaceutical Inc.: Capital Raising
Ultragenyx Pharmaceutical Inc.: Partnership
Ultragenyx Pharmaceutical Inc.: Divestments
Ultragenyx Pharmaceutical Inc.: Recent Developments
Ultragenyx Pharmaceutical Inc.: News and Events Summary
Ultragenyx Pharmaceutical Inc.: Corporate Governance
Ultragenyx Pharmaceutical Inc.: Financial Performance
Ultragenyx Pharmaceutical Inc.: Market Developments
Ultragenyx Pharmaceutical Inc.: Research & Development
Ultragenyx Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Ultragenyx Pharmaceutical Inc.: Key Facts
Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees
Table 3: Ultragenyx Pharmaceutical Inc.: Company History
Table 4: Ultragenyx Pharmaceutical Inc.: Key Competitors
Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Ultragenyx Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Ultragenyx Pharmaceutical Inc.: Targets and Partners
Table 9: Ultragenyx Pharmaceutical Inc.: Top Deals 2016 - 2020YTD*
Table 10: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: Ultragenyx Pharmaceutical Inc.: News and Events Summary
Table 20: Ultragenyx Pharmaceutical Inc.: Corporate Governance
Table 21: Ultragenyx Pharmaceutical Inc.: Financial Performance
Table 22: Ultragenyx Pharmaceutical Inc.: Market Developments
Table 23: Ultragenyx Pharmaceutical Inc.: Research & Development
Table 24: Ultragenyx Pharmaceutical Inc.: Strategy and Operations

★海外企業調査レポート[Ultragenyx Pharmaceutical Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Petrel Resources Plc (PET)：石油・ガス：M&Aディール及び事業提携情報
    Summary Petrel Resources Plc (Petrel Resources) is an oil and gas company that provides exploration and production of crude oil and natural gas across Iraq. The company provides areas of operations such as Luhais and Subba in Southern Iraq, Tano Basin in Ghana, Porcupine Basin in Ireland, and others …
  • Laing O’Rourke Plc：企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Armune BioScience Inc-医療機器分野：企業M&A・提携分析
    Summary Armune BioScience Inc (Armune) is a medical device company that develops and commercializes molecular diagnostic and prognostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests fo …
  • Northern Minerals Ltd (GPP)：企業の財務・戦略的SWOT分析
    Summary Northern Minerals Ltd (Northern Minerals) formerly known as Greenpower Energy Limited, is a mining, exploration and development company. The company’s business activities include acquisition, exploration, and development of petroleum, mineral and hydrothermal exploration properties. It explo …
  • SFJ Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary SFJ Pharmaceuticals Inc (SFJ Pharmaceuticals) is a drug company that provides funding and strategic development expertise services. The company offers management of phase III oncology clinical trials, phase II trials and regulatory approvals. Its services includes clinical operations, busine …
  • Juniper Pharmaceuticals Inc (JNP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women’s health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company uti …
  • Meredith Corporation：企業の戦略・SWOT・財務分析
    Meredith Corporation - Strategy, SWOT and Corporate Finance Report Summary Meredith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Chemo Espana SA-製薬・医療分野：企業M&A・提携分析
    Summary Chemo Espana SA (Chemo Group) is a pharmaceutical company, which conducts research, development, manufacture, sales and marketing of active pharmaceutical ingredients (APIs), finished dosage forms and branded pharmaceuticals. Its product portfolio includes steroids, hormones and antibiotics …
  • Standex International Corp：企業の戦略・SWOT・財務情報
    Standex International Corp - Strategy, SWOT and Corporate Finance Report Summary Standex International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Halo Pharma Inc-製薬・医療分野：企業M&A・提携分析
    Summary Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of m …
  • KPIT Technologies Ltd (KPIT)：企業の財務・戦略的SWOT分析
    KPIT Technologies Ltd (KPIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fresenius Medical Care AG & Co KGaA (FMS)：医療機器：M&Aディール及び事業提携情報
    Summary Fresenius Medical Care AG & Co KGaA (Fresenius Medical), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It is one of the largest kidney dialysis companies in the world. It provides dialysis care services and products to individuals with chronic kidney failure. It …
  • Modus Therapeutics Holding AB-製薬・医療分野：企業M&A・提携分析
    Summary Modus Therapeutics Holding AB (Modus), formerly known as Dilaforette Holding AB, is a biotechnology company that focuses on the development of sevuparin, a proprietary polysaccharide drug for the treatment of sickle cell disease (SCD). Modus Therapeutics Holding AB - Pharmaceuticals & Health …
  • Xbrane Biopharma AB (XBRANE)：企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products . The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It comb …
  • Isagen SA ESP：企業の戦略的SWOT分析
    Isagen SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Taiho Pharmaceutical Co Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group develops and markets pharmaceutical products in the field of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic agents, anti-tumor agents, H2 receptor …
  • Seven & i Holdings Co., Ltd. (3382)：企業の財務・戦略的SWOT分析
    Seven & i Holdings Co., Ltd. (3382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • HC Slingsby Plc：企業の戦略・SWOT・財務情報
    HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report Summary HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Alexza Pharmaceuticals Inc：医療機器：M&Aディール及び事業提携情報
    Summary Alexza Pharmaceuticals Inc (Alexza), a wholly owned subsidiary of Ferrer Therapeutics Inc, focuses on the research, development and commercialization of novel, proprietary products for the treatment of acute central nervous system diseases. The company develops all its products based on its …
  • Sumitomo Corp (8053)：石油・ガス：M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆